Literature DB >> 22160561

Glial reactivity in dogs with visceral leishmaniasis: correlation with T lymphocyte infiltration and with cerebrospinal fluid anti-Leishmania antibody titres.

Guilherme D Melo1, Gisele F Machado.   

Abstract

Visceral leishmaniasis is a multisystemic zoonotic disease that can manifest with several symptoms, including neurological disorders. Because glial cells are extensively associated with the immune response within the brain, we evaluated the morphology of astrocytes and microglia of dogs naturally infected with Leishmania chagasi. We used immunohistochemical and lectin-histochemical techniques for morphological analyses and we also examined the glial correlation with lymphocyte infiltration of the brain and with the presence of anti-Leishmania antibodies within the cerebrospinal fluid of the dogs. Although we did not detect a shared morphological pattern in the astrocytes or microglia in the brain tissue, these cells were more intensely labelled in infected dogs than in the control group. The density of microglia was increased in the ependymal/subependymal area, thus demonstrating a strong correlation with the presence of T lymphocytes and with cerebrospinal fluid antibody titres. Thus, our results indicate a pro-inflammatory state in the brains of dogs naturally infected with L. chagasi and strongly suggest that microglia and astrocytes are involved in the pathogenesis of the neurological disorders of visceral leishmaniasis in dogs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22160561     DOI: 10.1007/s00441-011-1290-7

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  7 in total

1.  Glial Fibrillary Acidic Protein and Ionized Calcium-Binding Adapter Molecule 1 Immunostaining Score for the Central Nervous System of Horses With Non-suppurative Encephalitis and Encephalopathies.

Authors:  Gisele Silva Boos; Klaus Failing; Edson Moleta Colodel; David Driemeier; Márcio Botelho de Castro; Daniele Mariath Bassuino; José Diomedes Barbosa; Christiane Herden
Journal:  Front Vet Sci       Date:  2021-07-09

2.  Unveiling Cerebral Leishmaniasis: parasites and brain inflammation in Leishmania donovani infected mice.

Authors:  Guilherme D Melo; Sophie Goyard; Laurence Fiette; Alexandre Boissonnas; Christophe Combadiere; Gisele F Machado; Paola Minoprio; Thierry Lang
Journal:  Sci Rep       Date:  2017-08-16       Impact factor: 4.379

3.  Main lesions in the central nervous system of dogs due to Leishmania infantum infection.

Authors:  Weline Lopes Macau; Joicy Cortez de Sá; Ana Patrícia de Carvalho da Silva; Alessandra Lima Rocha; Renata Mondêgo-Oliveira; Fábio Henrique Evangelista de Andrade; Caroline Magalhães Cunha; Kátia da Silva Calabrese; Ana Lucia Abreu-Silva
Journal:  BMC Vet Res       Date:  2017-08-18       Impact factor: 2.741

Review 4.  Biomarkers Associated With Leishmania infantum Exposure, Infection, and Disease in Dogs.

Authors:  Carla Maia; Lenea Campino
Journal:  Front Cell Infect Microbiol       Date:  2018-09-06       Impact factor: 5.293

5.  Ki-67 labeling in canine perianal glands neoplasms: a novel approach for immunohistological diagnostic and prognostic.

Authors:  Rodrigo Storti Pereira; Augusto Schweigert; Guilherme Dias de Melo; Fernando Vissani Fernandes; Felipe Augusto Ruiz Sueiro; Gisele Fabrino Machado
Journal:  BMC Vet Res       Date:  2013-04-20       Impact factor: 2.741

6.  T and B lymphocytes in the brains of dogs with concomitant seropositivity to three pathogenic protozoans: Leishmania chagasi, Toxoplasma gondii and Neospora caninum.

Authors:  Keila Priscilla Sakamoto; Guilherme Dias de Melo; Gisele Fabrino Machado
Journal:  BMC Res Notes       Date:  2013-06-08

7.  Zymographic patterns of MMP-2 and MMP-9 in the CSF and cerebellum of dogs with subacute distemper leukoencephalitis.

Authors:  Gisele F Machado; Guilherme D Melo; Milena S Souza; Andressa A Machado; Daniela S Migliolo; Olívia C Moraes; Cáris M Nunes; Erica S Ribeiro
Journal:  Vet Immunol Immunopathol       Date:  2013-04-11       Impact factor: 2.046

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.